Small-and medium-sized hepatocellular carcinomas: Monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results

Radiology

Volumn 268, Issue 2, 2013, Pages 589-600

  Woo, Sungmin ^a   Lee, Jeong Min ^a,b   Yoon, Jeong Hee ^a,c   Joo, Ijin ^a   Kim, Se Hyung ^a,b   Lee, Jae Young ^a,b   Yoon, Jung Hwan ^c   Kim, Yoon Jun ^c   Han, Joon Koo ^a,b   Choi, Byung Ihn ^a,b  

^a Department of Radiology ^*  (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN;

ABSCESS; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERY BLEEDING; ARTICLE; BLEEDING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COLON SWELLING; COLON WALL PERFORATION; ELECTRODE; FEMALE; GALLBLADDER SWELLING; GASTROINTESTINAL DISEASE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE SWITCHING SYSTEM; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SAFETY; STOMACH SWELLING; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; HUMANS; IOHEXOL; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84880670391     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121736     Document Type: Article

References (53)

1. Lencioni R, Cioni D, Crocetti L, et al. Earlystage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percuta neous image-guided radiofrequency ablation. Radiology 2005;234(3):961-967.
2. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg 1998;227(4):566-571.
3. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: The real impact of the surgical margin. Eur J Surg Oncol 1998;24(3):174-179.
4. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: Correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 2007;188(2):480-488.
5. Seror O, N'Kontchou G, Tin-Tin-Htar M, et al. Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis. J Vasc Interv Radiol 2008;19(5):718-724.
6. Yang B, Zou J, Xia J, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation. Eur J Radiol 2011;79(2):196-200.
7. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: Challenges and opportunities-part II. J Vasc Interv Radiol 2001;12(10):1135- 1148.
8. Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: Influence of technique and tumor size. Surgery 2002;132(4):605-611; discussion 611-612.
9. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology 2000;214(3):761-768.
10. Waki K, Aikata H, Katamura Y, et al. Percutaneous radiofrequency ablation as firstline treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 2010;25(3):597-604.
11. Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12(7):1098-1104.
12. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129(1):122-130.
13. Horigome H, Nomura T, Nakao H, et al. Percutaneous radio-frequency ablation therapy using a clustered electrode for malignant liver tumors. J Clin Gastroenterol 2001;32(5):418-422.
14. Miao Y, Ni Y, Yu J, Zhang H, Baert A, Marchal G. An ex vivo study on radiofrequency tissue ablation: Increased lesion size by using an "expandable-wet" electrode. Eur Radiol 2001;11(9):1841-1847.
15. Lee JM, Han JK, Kim HC, et al. Multiple-electrode radiofrequency ablation of in vivo porcine liver: Comparative studies of consecutive monopolar, switching monopolar versus multipolar modes. Invest Radiol 2007;42(10):676-683.
16. Crocetti L, Lencioni R, Debeni S, See TC, Pina CD, Bartolozzi C. Targeting liver lesions for radiofrequency ablation: An experimental feasibility study using a CT-US fusion imaging system. Invest Radiol 2008;43(1):33-39.
17. Chen MH, Yang W, Yan K, et al. Large liver tumors: Protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 2004;232(1):260-271.
18. Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001;177(4):777-782.
19. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: Techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001;26(4):345-360.
20. Laeseke PF, Sampson LA, Haemmerich D, et al. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: In vivo porcine liver results. Radiology 2006;241(1):116-124.
21. Lee J, Lee JM, Yoon JH, et al. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol 2012;13(1):34-43.
22. Weisbrod AJ, Atwell TD, Callstrom MR, Farrell MA, Mandrekar JN, Charboneau JW. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system. J Vasc Interv Radiol 2007;18(12):1528-1532.
23. Laeseke PF, Frey TM, Brace CL, et al. Multiple-electrode radiofrequency ablation of hepatic malignancies: Initial clinical experience. AJR Am J Roentgenol 2007;188(6):1485-1494.
24. Hänsler J, Frieser M, Tietz V, et al. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes. J Vasc Interv Radiol 2007;18(3):405-410.
25. Lee ES, Lee JM, Kim WS, et al. Multipleelectrode radiofrequency ablations using Octopus ® electrodes in an in vivo porcine liver model. Br J Radiol 2012;85(1017):e609-e615.
26. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42(5):1208-1236.
27. Lee JM, Han JK, Kim HC, et al. Switching monopolar radiofrequency ablation technique using multiple, internally cooled electrodes and a multichannel generator: Ex vivo and in vivo pilot study. Invest Radiol 2007;42(3):163-171.
28. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2005;16(6):765-778.
29. Nam SY, Rhim H, Kang TW, et al. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: Clinical assessment of the heat-sink effect of artificial ascites. AJR Am J Roentgenol 2010;194(2):W227-W231.
30. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: Current status. AJR Am J Roentgenol 2001;176(1):3-16.
31. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: Evaluation with follow-up multiphase helical CT. Radiology 2001;221(2):447-454.
32. Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: Helical CT patterns. Abdom Imaging 2001;26(4):375-383.
33. O'Connor OJ, Maher MM. Imaging of cholecystitis. AJR Am J Roentgenol 2011;196(4):W367-W374.
34. Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: Inflammatory disease. RadioGraphics 2000;20(2):399-418.
35. Kim JH, Kim PN, Won HJ, Shin YM. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma. AJR Am J Roentgenol 2012;198(2):471-476.
36. Lin SM, Lin CC, Chen WT, Chen YC, Hsu CW. Radiofrequency ablation for hepatocellular carcinoma: A prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007;18(9):1118-1125.
37. Laeseke PF, Sampson LA, Frey TM, et al. Multiple-electrode radiofrequency ablation: Comparison with a conventional cluster electrode in an in vivo porcine kidney model. J Vasc Interv Radiol 2007;18(8): 1005-1010.
38. Haemmerich D, Lee FT Jr. Multiple applicator approaches for radiofrequency and microwave ablation. Int J Hyperthermia 2005;21(2):93-106.
39. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma , or =4 cm. Gastroenterology 2004;127(6):1714-1723.
40. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54(8):1151-1156.
41. Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: Prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006;238(1):346-353.
42. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 1999;229(2):216-222.
43. Wang Y, Chen Y, Ge N, et al. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization. Ann Surg Oncol 2012;19(11):3540-3546.
44. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000;31(4):302-308.
45. Farinati F, Marino D, De Giorgio M, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: Both or neither? Am J Gastroenterol 2006;101(3):524-532.
46. Okuwaki Y, Nakazawa T, Kokubu S, et al. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Am J Gastroenterol 2009;104(11):2747-2753.
47. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors. Eur J Radiol 2006;59(3):432-441.
48. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: Treatment and follow-up in 16 patients. Radiology 1997;202(1):195-203.
49. Chen MH, Yang W, Yan K, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol 2005;11(40):6395-6401.
50. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003;226(2):441-451.
51. Choi D, Lim HK, Rhim H, et al. Percutaneous ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large singleinstitution series. Eur Radiol 2007;17(3):684-692.
52. Yamanaka Y, Shiraki K, Miyashita K, et al. Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. World J Gastroenterol 2005;11(14):2174-2178.
53. Izumi N, Asahina Y, Noguchi O, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001;91(5):949-956.